Analysis of the INVESDOR Newsletter
1. Contents of the Newsletter:
The newsletter from INVESDOR highlights two distinct investment opportunities for investors. It provides insights into Neuro Event Labs and FOX Living II. Neuro Event Labs offers an AI-powered seizure monitoring system that is already in clinical use, with impressive milestones such as CE marking, FDA clearance, monitoring of 7,000+ patients, and substantial revenue generation. On the other hand, FOX Living II presents an opportunity with a 7.75% p.a. interest rate, showcasing progress from its previous financing round and the current phase of construction commencement.
2. Products:
Neuro Event Labs offers Nelli, an AI-powered, contact-free seizure-monitoring system that has been successfully used in clinical settings. The system has obtained CE marking as a Class IIa medical device in Europe, FDA clearance for use in U.S. hospitals, monitored over 7,000 patients across 60+ hospitals, and generated revenue of €1.2m in 2025. Similarly, FOX Living II presents an investment opportunity with a 7.75% p.a. interest rate, indicating progress from its previous financing round and the initiation of the construction phase.
3. Store INVESDOR (invesdor.nl):
INVESDOR is an investment platform that provides opportunities for investors to explore and invest in various projects. The store seems to focus on MedTech and construction projects, as evidenced by the investment opportunities in Neuro Event Labs and FOX Living II. The platform offers detailed information about the projects, including milestones, financial data, and growth plans, allowing investors to make informed decisions. For further inquiries or questions, investors can reach out to the CEO Martijn Wallert or the customer service email provided in the newsletter.
